Company Summary
VIBHA VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED
Services/Health Care Services
SETWB
CG Report:   -
 
  Data as of 18 Oct 2021  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
2.16 2.68 / 1.42 35.65 3.29 1,357.59 29,323.87 43,394.74 925.40 25.33
News
Date/Time Subject
01 Oct 2021 17:10   Report on the results of the Exercise of ESOP-W2 (F53-5)
01 Oct 2021 17:09   Report on the results of the Exercise of VIBHA-W3 (F53-5)
14 Sep 2021 12:36   Notification the exercise of VIBHA-W3 (Revise)
13 Sep 2021 17:06   Notification the exercise of VIBHA-W3
13 Aug 2021 18:14   Financial Performance Quarter 2 (F45) (Reviewed)
more

Company Profile
Address 51/3 NGAMWONGWAN RD., LATYAO, JATUJAK Bangkok 10900
Telephone 0-2579-9680-4, 0-2561-1258-67, 0-2941-2800
Fax 0-2561-1466, 0-2561-1462
URL http://www.vibhavadi.com
Establish Date 01/3/1986 Listed Date 26/03/1992
IPO Price (Baht) 31.00 @Par10.00 Baht
IPO Financial Advisory
  • MEC FAR EAST INTERNATIONAL PUBLIC COMPANY LIMITED
  • Par 0.10 Baht
    Last Par Change Old 1.00 : New 0.10 @ 22/05/2015

    Business
    Hotpital

    Free Float 19 Mar 2021 20 Mar 2020
    % /Shareholders
    33.40% 13,189 35.44% 10,278
    Foreign Shareholders 0.55% (As of 18/10/2021) Foreign Limit 40.00%
    NVDR Shareholders  0.25% (As of 18/10/2021)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days - -1.30 -0.27
    20 Days -1.82 -2.39 -2.91
    60 Days -12.20 -11.84 -15.91
    120 Days 3.85 -4.86 -2.15
    YTD 46.94 22.77 29.55
    P/E (X) 35.65 48.72 21.01
    P/BV (X) 3.29 4.38 1.77
    Turnover Ratio (%) 0.06 0.18 1.53

    Top 10 Major Shareholders(@10 May 2021) Share %
    1. บริษัท เอฟแอนด์เอส 79 จำกัด 2,083,909,966 15.35
    2. MR. CHAISITH VIRIYAMETTAKUL 2,023,100,000 14.90
    3. บริษัท สินแพทย์ จำกัด 1,188,400,566 8.75
    4. บริษัท โรงพยาบาลรามคำแหง จำกัด (มหาชน) 962,605,200 7.09
    5. บริษัท โรงพยาบาลเจ้าพระยา จำกัด (มหาชน) 803,634,195 5.92
    6. บริษัท โรงพยาบาลวิภาราม จำกัด 564,043,133 4.15
    7. MR. PHITJIT WIRIYAMETTAKUL 446,000,000 3.29
    8. MR. PISUTH VIRIYAMETTAKUL 441,400,000 3.25
    9. นาย เอื้อชาติ กาญจนพิทักษ์ 174,802,916 1.29
    10. น.ส. นิรมล วิริยะเมตตากุล 169,430,000 1.25

    Management Position
    1. Mr. NIKOM WAIRATPANIJ CHAIRMAN OF THE BOARD DIRECTOR / INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    2. Mr. CHAISITH VIRIYAMETTAKUL CHAIRMAN OF EXECUTIVE DIRECTOR / DIRECTOR
    3. Mr. PHIJIT WIRIYAMETTAKUL MANAGING DIRECTOR / DIRECTOR
    4. Mr. RACHA SOMBURANASIN DIRECTOR
    5. Mr. CHAMNAN CHANAPAI DIRECTOR
    6. Mr. PONGPAT PATANAVANICH DIRECTOR
    7. Miss RUKKAGEE KANJANAPITAK DIRECTOR
    8. Mrs. BAVORNPHAN RATHPRASERT DIRECTOR
    9. Mr. SITTHI PANUPATTANAPONG DIRECTOR
    10. Mrs. YADA PUTTHKAYON DIRECTOR
    11. Mr. PRAMUK UNACHAK DIRECTOR
    12. GEN. BOONLOET CHUNTARAPAS INDEPENDENT DIRECTOR
    13. Mr. CHAINARIN SAIRUNGSRI INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    14. Mr. SIROTE SWASDIPANICH INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    15. Mr. PRASERT SRIURANPONG INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    18 Oct 2021
    2020
    30 Dec 2020
    2019
    30 Dec 2019
    Listed share (M.) 13,575.87  13,575.87  13,264.62 
    Market Cap (MB.) 29,323.87  19,956.52  23,743.66 
    Price (B./share) 2.16  1.47  1.79 
    BVPS (B./Share) 0.66  0.57  0.58 
    P/BV (X) 3.29  2.60  3.12 
    P/E (X) 35.65  67.71  31.50 
    Turnover Ratio (%) 60.72  7.94  11.22 
    Value Trade/Day (MB.) 95.74  6.80  11.60 
    Beta 0.35  0.56  0.44 
     
    Rate of Return YTD  2020  2019 
    Price Change (%) 46.94  -17.88  -10.50 
    Dividend Yield (%) 1.85  2.99  2.22 
    Payout Ratio 0.66  2.03  0.70 
    Dividend Policy No less than 80% of the Company?s net profit after deducting legal reserves and other reserves (if any)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2020 - 31 Dec 2020 0.04 Baht 24 May 2021 Cash
    01 Jan 2019 - 31 Dec 2019 0.045 Baht 27 May 2020 Cash
    01 Jan 2018 - 31 Dec 2018 0.04 Baht 23 May 2019 Cash
     
    Auditor
    (Effective Until 31/12/2021)
    MR. PERADATE PONGSATHIANSAK/DHARMNITI AUDITING CO., LTD.
    MR. THANAWUT PIBOONSAWAT/DHARMNITI AUDITING CO., LTD.
    MR. SUWAT MANEEKANOKSAKUL/DHARMNITI AUDITING CO., LTD.
    MISS SORAYA TINTASUWAN/DHARMNITI AUDITING CO., LTD.
    Miss POTJANARAT SIRIPIPAT/DHARMNITI AUDITING CO., LTD.
    Miss ROONGNAPHA SAENGCHAN/DHARMNITI AUDITING CO., LTD.
    Miss TECHINEE PORNPENPOB/DHARMNITI AUDITING CO., LTD.
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion with an emphasis of matters
    Financial Data
    Statement of Financial Position (MB.) 6M/2021 
    (01/01/21 
    -30/06/21) 
    6M/2020 
    (01/01/20 
    -30/06/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 340.79 508.15 338.29 602.86 307.12
    A/R Net 624.46 492.25 639.66 592.60 677.69
    Inventories 167.03 212.52 164.93 174.56 165.28
    Current Assets 2,165.71 1,501.79 1,521.33 1,718.79 1,526.35
    PP&E Net 8,328.94 7,379.95 7,970.09 7,024.74 6,125.50
    Non-Current Assets 21,153.65 18,353.16 19,653.68 17,911.06 14,021.03
    Total Assets 23,319.36 19,854.95 21,175.02 19,629.85 15,547.38
    OD 3,492.20 2,923.79 2,605.90 2,677.94 1,585.79
    A/P Net 452.25 309.78 376.94 431.45 368.53
    Current portion of LT 1,112.62 811.91 1,065.16 843.18 743.11
    Current Liabilities 6,424.61 5,334.07 5,304.90 5,359.02 4,002.96
    Non-Current Liabilities 5,454.98 4,557.64 5,136.10 3,899.17 2,168.93
    Total Liabilities 11,879.59 9,891.72 10,441.00 9,258.19 6,171.89
    Authorized Capital 1,493.91 1,493.91 1,493.91 1,493.78 1,493.78
    Paid-Up Capital 1,357.59 1,326.46 1,357.59 1,326.46 1,319.94
    Premium (Discount) on Share Capital 2,718.14 2,438.33 2,718.14 2,438.33 2,379.36
    Retained Earnings (Deficit) 2,511.81 2,176.05 2,598.52 2,614.08 2,342.02
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity 2,320.16 1,501.46 1,496.41 1,409.71 1,066.01
     - Surplus (Deficits) - - - - -
    Shareholders' Equity 8,907.70 7,442.30 8,170.65 7,788.59 7,107.33
    Minority Interest 2,532.07 2,520.94 2,563.37 2,583.08 2,268.16
    more
    Statement of Comprehensive Income (MB.) 6M/2021 
    (01/01/21 
    -30/06/21) 
    6M/2020 
    (01/01/20 
    -30/06/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 3,109.96 2,866.49 6,024.45 6,545.89 6,474.04
    Other Income 48.56 48.14 121.71 116.16 96.36
    Total Revenues 3,274.21 3,004.83 6,338.25 6,872.48 6,651.23
    Costs 2,289.31 2,156.84 4,485.88 4,778.58 4,529.49
    Selling And Administrative Expenses 459.73 478.60 925.04 953.47 915.85
    Total Cost And Expenses 2,749.04 2,635.43 5,410.92 5,732.05 5,445.34
    EBITDA 925.40 516.08 1,303.67 1,813.73 1,638.06
    Depre. & Amor. 218.36 221.76 438.69 413.38 412.54
    EBIT 707.04 294.32 864.98 1,400.35 1,225.52
    Net Profit : Owners Of The Parent 463.41 90.63 449.80 809.05 723.67
    EPS (B.) 0.03 0.01 0.03 0.06 0.05
    more
    Statement of Cash Flow (MB.) 6M/2021 
    (01/01/21 
    -30/06/21) 
    6M/2020 
    (01/01/20 
    -30/06/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow 784.11 479.95 1,094.74 1,526.56 1,197.66
    Investing Cash Flow -1,053.20 -654.11 -1,669.28 -3,087.83 -662.81
    Financing Cash Flow 271.59 79.46 309.98 1,857.01 -660.32
    Net Cash Flow 2.50 -94.70 -264.56 295.73 -125.47
    more
    Annualized: ROE, ROA
    Ratios 6M/2021  6M/2020  2020  2019 
    Current Ratio (X) 0.34 0.28 0.29 0.32
    ROE (%) 10.06 8.47 5.64 10.86
    ROA (%) 5.92 6.14 4.24 7.96
    D/E (X) 1.04 0.99 0.97 0.89
    Total Asset Turnover (X) 0.31 0.34 0.31 0.39
    Gross Profit Margin (%) 26.39 24.76 25.54 27.00
    EBIT Margin (%) 21.59 9.79 13.65 20.38
    Net Profit Margin (%) 15.83 4.91 8.50 14.45

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 6M/2021  6M/2020  2020  2019 
    Sales Growth 8.49 -7.99 -7.97 1.11
    COGs Growth 6.14 -7.86 -6.13 5.50
    Total Revenue Growth 8.96 -9.28 -7.77 3.33
    Total Expense Growth 4.31 -7.09 -5.60 5.27
    Net Profit Growth 411.31 -65.62 -44.40 11.80

    Annualized
    Cash Cycle 6M/2021  6M/2020  2020  2019 
    A/R Turnover (Times) 11.23 10.18 9.78 10.31
    Avg. Collection Period (Days) 32.51 35.86 37.33 35.42
    Inventory Turnover (Times) 24.34 24.40 26.43 28.12
    Avg. Inventory Period (Days) 15.00 14.96 13.81 12.98
    A/P Turnover (Times) 13.96 13.65 11.10 11.95
    Avg. Payment Period (Days) 26.15 26.75 32.89 30.55
    Cash Cycle (Days) 21.36 24.07 18.25 17.84


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name VIBHA-W3

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.